Abstract
Oral anticoagulants (OACs) reduce the risk of stroke for people with atrial fibrillation (AF), and OACs are recommended in evidence-based guidelines for most people with AF.1 The net clinical benefit of OACs compared with no treatment or aspirin is clear for most people with AF, apart from those at lowest stroke risk.2 The common risk factors for incident AF are also risk factors for stroke and bleeding in AF.3
Original language | English |
---|---|
Pages (from-to) | 1807-1810 |
Number of pages | 4 |
Journal | Journal of the American Geriatrics Society |
Volume | 69 |
Issue number | 7 |
Early online date | 24 Apr 2021 |
DOIs | |
Publication status | Published - Jul 2021 |
Externally published | Yes |
Keywords
- Frailty
- Atrial fibrillation
- Cognitive impairment
- Oral anticoagulants
- Stroke